In Vitro Diagnostic at MEDICA
MEDICA 20–22 November 2013 Dusseldorf, Germany
Focus on In Vitro Diagnostic
MEDICA was the right place to meet: companies developing products, raw materials or services for In Vitro Diagnostic (IVD), distributors. Sales and marketing managers as well as researchers were present on the booths.
With 132 000 visits in 4 days event for MEDICA & COMPAMED, 3 halls out of 18 were focusing on IVD. Around 800 IVD companies were exhibiting, coming mainly from Germany (245 companies) and the US (116 companies).
In Europe, the UK pavilion was hosting 62 exhibitors, the French pavilion only presented 35 exhibitors, the Belgium Pavilion had 28 exhibitors. The Scandinavian countries also had a low representation with only 35 exhibitors in total.
In Asia- Pacific, the Korean companies were leading with 40 exhibitors, while Japanese companies were following with only 16 companies. And companies from Australia and New Zeland were almost not presented.
Despite a high market potential, the BRICS presence was still shy and was led by India (23 companies), followed by China (12 companies), Brazil (6 companies), Russia (3 companies).
Innovation in IVD
Innovation in IVD was not easy to detect. Few suppliers propose multiplex assays to detect proteins: Randox, Mikrogen, Theradiag… The next revolution might come from a Swedish research laboratory (Acreo Swedish ICT research institute in collaboration with The Biosensors and Bioelectronics center at Linköping University) with an integrated biosensor using electrically conductive ink, with a cost estimate around 0.5 euros /test for larger production. The prototype has been developed for Self-monitoring Blood Glucose (SMBG) but could be adapted to other area: cancer, heart disease, infectious disease … and the concept is waiting for partners for industrialization.
https://www.acreo.se/media/news/new-swedish-printed-biosensor-for-low-cost-detection
Next event: 12-15 November 2014 :
http://www.medica-tradefair.com/
Author : Nathalie Accornero, Ao Marketing Life Sciences
Discover our services in Marketing & Business Development:
Other diagnostics events in 2014
All News in Molecular Diagnostics
Last News
- Note de réflexion de fin d’année
- EMA re-examines its opinion and approves Leqembi for the treatment of Alzheimer’s disease
- Le déclassement de la France
Events
News archives
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- March 2024
- February 2024
- January 2024
- November 2023
- September 2023
- July 2023
- April 2023
- March 2023
- January 2023
- December 2022
- November 2022
- October 2022
- August 2022
- June 2022
- May 2022
- April 2022
- March 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- October 2018
- June 2018
- May 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- September 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- June 2014
- May 2014
- April 2014
- March 2014
- January 2014
- November 2013
- September 2013
- July 2013
- May 2013
- April 2013
- March 2013
- January 2013
- December 2012
- November 2012
- October 2012
- March 2012